For instance, given the small sizes of these biopsies and the prominent morphological intra- and inter-lesion heterogeneity of advanced NSCLC, these phenotypic changes may not necessarily be represented in the examined tissue samples and therefore can be missed in certain patients that are resistant to EGFR-TKIs. Here, EGFR is linked to non-small cell lung carcinoma.